Available documents

Overview

Impressive advances in medicine and technology have boosted health and extended life expectancy – but not for everyone. Vital new medicines for diseases such as HIV/AIDS are priced out of reach of the millions of sick people in the developing world, in part due to global patent rules which restrict the availability of affordable generic versions of patented medicines. In 2001, all members of the World Trade Organization adopted the ‘Doha Declaration’, promising to prioritize public health over private patent rights and to promote ‘access to medicines for all’. This paper examines how the government of the United States is contravening this commitment by using technical assistance, bilateral and regional trade agreements, and the threat of trade sanctions to ratchet up patent protection in developing countries. This policy benefits the influential U.S. pharmaceutical industry while pushing medicines further out of the reach of poor people.

Additional details

Author(s)

Publisher(s)

ISBN

978-1-84814-592-4

How to cite this resource

Citation styles vary so we recommend you check what is appropriate for your context.  You may choose to cite Oxfam resources as follows:

Author(s)/Editor(s). (Year of publication). Title and sub-title. Place of publication: name of publisher. DOI (where available). URL

Our FAQs page has some examples of this approach.

Related resources

Here are similar items you might be interested in.

Browse all resources